Law360, New York (June 30, 2011, 8:07 PM ET) -- Elan Pharma International Ltd. and a subsidiary of Abbott Laboratories on Thursday dropped a New Jersey suit accusing Teva Pharmaceuticals USA Inc. of infringing three patents for cholesterol drug Tricor.
U.S. District Judge Garrett E. Brown Jr. approved a joint motion to dismiss the case, which Elan and Abbott subsidiary Fournier Laboratories Ireland Ltd. brought in July 2010.
Neither side admitted any liability, and both will pay their own fees, according to the motion. They did not disclose whether their deal to drop the case had...
Elan, Abbott Drop Teva Patent Suit Over Tricor
To view the full article, take a free trial now.
